Procter & Gamble Hygiene Q2 FY27: Revenue Rs 1,145.08 cr; PAT down 6.7%
Procter & Gamble Hygiene and Health Care Ltd reported Q2 FY27 revenue from operations of Rs 1,145.08 cr and PAT of Rs 195.84 cr, versus Rs 1,150.17 cr and Rs 209.86 cr a year earlier.
Key takeaways
- Revenue from operations Rs 1,145.08 cr vs Rs 1,150.17 cr in Q2 FY26.
- Total income Rs 1,162.09 cr vs Rs 1,160.07 cr in the year-ago quarter.
- Total expenses rose to Rs 900.07 cr from Rs 878.29 cr a year earlier.
- Profit after tax Rs 195.84 cr vs Rs 209.86 cr in Q2 FY26.
- Basic and diluted EPS Rs 60.33 vs Rs 64.65 in the corresponding quarter.
Q2 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 1,145.08 cr | Rs 1,150.17 cr | -0.4% |
| PAT | Rs 195.84 cr | Rs 209.86 cr | -6.7% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 17.10% of revenue, down 114 bps from 18.25%.
- Total expenses rose 2.5% while revenue fell 0.4%.
• Revenue from operations for the quarter ended 30th September 2026: Rs 1,145.08 cr (Q2 FY26: Rs 1,150.17 cr), as per the statement of financial results.
• Other income for the quarter ended 30th September 2026: Rs 17.01 cr (Q2 FY26: Rs 9.90 cr).
• Total income (revenue from operations + other income) for the quarter ended 30th September 2026: Rs 1,162.09 cr (Q2 FY26: Rs 1,160.07 cr).
• Total expenses for the quarter ended 30th September 2026: Rs 900.07 cr (Q2 FY26: Rs 878.29 cr).
• Profit before tax for the quarter ended 30th September 2026: Rs 262.02 cr (Q2 FY26: Rs 281.78 cr).
• Profit for the period (profit after tax) for the quarter ended 30th September 2026: Rs 195.84 cr (Q2 FY26: Rs 209.86 cr).
• Basic earnings per share (not annualised) for the quarter ended 30th September 2026: Rs 60.33 (Q2 FY26: Rs 64.65).
• Diluted earnings per share (not annualised) for the quarter ended 30th September 2026: Rs 60.33 (Q2 FY26: Rs 64.65).
According to the standalone statement of unaudited financial results for the quarter and six months ended 30th September 2026, Procter & Gamble Hygiene and Health Care Ltd’s revenue from operations for Q2 FY27 was Rs 1,145.08 cr, marginally lower than Rs 1,150.17 cr in the corresponding quarter of the previous year. Including other income of Rs 17.01 cr (versus Rs 9.90 cr a year earlier), total income for the quarter stood at Rs 1,162.09 cr compared with Rs 1,160.07 cr in Q2 FY26.
Total expenses rose to Rs 900.07 cr in Q2 FY27 from Rs 878.29 cr in Q2 FY26. Within expenses, cost of raw and packing materials consumed was Rs 237.87 cr (Q2 FY26: Rs 197.49 cr), purchases of stock-in-trade (traded goods) were Rs 237.52 cr (Q2 FY26: Rs 211.64 cr), and advertising & sales promotion expenses were Rs 166.52 cr (Q2 FY26: Rs 175.97 cr). Other expenses were Rs 193.40 cr versus Rs 195.65 cr a year earlier. Profit before tax for the quarter was Rs 262.02 cr, compared with Rs 281.78 cr in the same quarter last year.
After income tax expense of Rs 66.18 cr (Q2 FY26: Rs 71.92 cr), profit for the period came in at Rs 195.84 cr, down from Rs 209.86 cr in the corresponding prior-year quarter. Basic and diluted earnings per share (face value Rs 10 per share, not annualised) for Q2 FY27 were both Rs 60.33, compared with Rs 64.65 in Q2 FY26, as reported in the statement of financial results.
Get Procter & Gamble Hygiene and Health Care Ltd's next results the minute they're filed
Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.
- We'll start you off following PGHH.
- 14 days free, no card. After that you keep a free account.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.